1-20 of 38
Paul B. Koller
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Favorable Survival Outcomes in AML Patients Undergoing Allogeneic Hematopoietic Cell Transplant with Fludarabine/Melphalan-Conditioning with Tacrolimus/Sirolimus-Based Gvhd Prophylaxis

Amandeep Salhotra, Monzr M. Al Malki, Dongyun Yang, Sally Mokhtari, Ibrahim Aldoss, Ahmed Aribi, Idoroenyi Amanam, Haris Ali, Karamjeet S. Sandhu, Vaibhav Agrawal, Paul B. Koller, Brian J. Ball, Shukaib Arslan, Salman Otoukesh, Amanda Blackmon, Hoda Pourhassan, Yazeed Samara, Tamer Othman, Pamela S. Becker, Vinod Pullarkat, Ricardo Spielberger, Forest Marc Stewart, Eileen Patricia Smith, Andrew Artz, Stephen J. Forman, Guido Marcucci, Anthony Stein, Ryotaro Nakamura
Journal: Blood
Blood (2023) 142 (Supplement 1): 4959.
https://doi.org/10.1182/blood-2023-187156
Published: 2023
Journal Articles

A Phase 1a/b Trial of Luxeptinib (CG-806) in Patients with Relapsed/Refractory B-Cell Malignancies or Acute Myeloid Leukemia and Evaluation of New G3 Formulation

Aaron D. Goldberg, Felipe Samaniego, Maro Ohanian, Paul B. Koller, Namrata Sonia Chandhok, Ahad A. Sadiq, Daruka Mahadevan, Mohamad A. Cherry, Jessica K. Altman, John M. Burke, Michael Z. Koontz, J. C. C Villasboas, Ben K. Tomlinson, Laura E. Finn, Erin G Reid, Jason Melear, Victor Priego, Patrick Cobb, Elizabeth Heritage Cull, Paul Conkling, David Cosgrove, Lindsey E. Roeker, Eric Tam, Donna Nguyen Haney, Jia Hu, Ranjeet Sinha, Nawazish Khan, William G. Rice, Rafael Bejar
Journal: Blood
Blood (2023) 142 (Supplement 1): 5953.
https://doi.org/10.1182/blood-2023-181151
Published: 2023
Journal Articles

Tuspetinib Myeloid Kinase Inhibitor Safety and Efficacy As Monotherapy and Combined with Venetoclax in Phase 1/2 Trial of Patients with Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML)

Naval Daver, Kyoo Hyung Lee, Yunsuk Choi, Brian A. Jonas, Martha Arellano, Paul B. Koller, Chul W. Jung, Sang Kyun Sohn, Amir T. Fathi, Jeong-Ok Lee, Sung-Soo Yoon, Justin M. Watts, Pankit Vachhani, Ho-Jin Shin, Jia Hu, Ranjeet Sinha, Nawazish Khan, William G. Rice, Rafael Bejar
Journal: Blood
Blood (2023) 142 (Supplement 1): 162.
https://doi.org/10.1182/blood-2023-182296
Published: 2023
Journal Articles

Update of Olverembatinib (HQP1351) Overcoming Ponatinib and/or Asciminib Resistance in Patients (Pts) with Heavily Pretreated/Refractory Chronic Myeloid Leukemia (CML) and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph + ALL)

Elias Jabbour, Hagop M. Kantarjian, Paul B. Koller, Omer Jamy, Vivian G. Oehler, Elza Lomaia, Anthony M. Hunter, Olga Uspenskaya, Svetlana Samarina, Sudipto Mukherjee, Maria R. Baer, Vera Zherebtsova, Vasily Shuvaev, Anna Turkina, Igor Davydkin, Jorge Cortes, Huanshan Guo, Zi Chen, Lei Fu, Hengbang Wang, Lixin Jiang, Cunlin Wang, Dajun Yang, Yifan Zhai
Journal: Blood
Blood (2023) 142 (Supplement 1): 1798.
https://doi.org/10.1182/blood-2023-187744
Published: 2023
Journal Articles

Improving Outcomes of Peripheral Blood Stem Cell (PBSC) HLA-Mismatched Unrelated Donor (MMUD) Hematopoietic Cell Transplantation (HCT): Effect of Graft Versus Host Disease (GVHD) Prophylaxis

Vaibhav Agrawal, Dongyun Yang, Sally Mokhtari, Tamer Othman, Yazeed Samara, Amanda Blackmon, Hoda Pourhassan, Brian J. Ball, Idoroenyi Amanam, Shukaib Arslan, Salman Otoukesh, Paul B. Koller, Karamjeet S. Sandhu, Ibrahim Aldoss, Haris Ali, Amandeep Salhotra, Ahmed Aribi, Andrew Artz, Pamela S. Becker, Vinod Pullarkat, Forest Marc Stewart, Eileen Patricia Smith, Anthony Stein, Guido Marcucci, Stephen J. Forman, Ryotaro Nakamura, Monzr M. Al Malki
Journal: Blood
Blood (2023) 142 (Supplement 1): 4896.
https://doi.org/10.1182/blood-2023-187909
Published: 2023
Journal Articles

ASC2ESCALATE: A US Phase 2, Open-Label, Single-Arm, Dose-Escalation Study of Asciminib (ASC) Monotherapy in Patients (Pts) with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) As Second-Line (2L) and First-Line (1L) Treatment

Ehab L. Atallah, Michael Mauro, Koji Sasaki, Moshe Levy, Paul B. Koller, Daisy Yang, Dramane Laine, John Sabo, Ennan GU, Jorge Cortes
Journal: Blood
Blood (2023) 142 (Supplement 1): 6389.
https://doi.org/10.1182/blood-2023-186974
Published: 2023
Journal Articles

Total Marrow and Lymphoid Irradiation (TMLI) -Based Conditioning Regimen in Patients with Acute Leukemia Undergoing Allogeneic Hematopoietic Cell Transplant with Measurable Residual Disease

Amandeep Salhotra, Monzr M. Al Malki, Dongyun Yang, Sally Mokhtari, Ahmed Aribi, Ibrahim Aldoss, Vinod Pullarkat, Ricardo Spielberger, Pamela S. Becker, Karamjeet S. Sandhu, Haris Ali, Amanda Blackmon, Brian J. Ball, Paul B. Koller, Salman Otoukesh, Shukaib Arslan, Vaibhav Agrawal, Firoozeh Sahebi, Susanta Hui, Guido Marcucci, Ryotaro Nakamura, Jeffrey Wong, Anthony Stein
Journal: Blood
Blood (2023) 142 (Supplement 1): 2162.
https://doi.org/10.1182/blood-2023-185034
Published: 2023
Journal Articles

Consolidation with First and Second Allogeneic Transplants in Adults with Relapsed/Refractory B-ALL Following Response to CD19CAR T Cell Therapy

Ibrahim Aldoss, Haoyue Shan, Dongyun Yang, Mary C Clark, Monzr M. Al Malki, Ahmed Aribi, Karamjeet S. Sandhu, Amandeep Salhotra, Vaibhav Agrawal, Hoda Pourhassan, Paul B. Koller, Haris Ali, Andrew Artz, Idoroenyi Amanam, Nicole Karras, Anna Pawlowska, Lindsey Murphy, Joycelynne Michelle Palmer, Guido Marcucci, Anthony Stein, Vinod Pullarkat, Ryotaro Nakamura, Stephen J. Forman
Journal: Blood
Blood (2023) 142 (Supplement 1): 4981.
https://doi.org/10.1182/blood-2023-182058
Published: 2023
Journal Articles

Outcomes of Patients Undergoing Fludarabine and Melphalan-Based Conditioning with Post-Transplant Cyclophosphamide for Peripheral Blood Stem Cell Allogeneic Hematopoietic Cell Transplant: Donor Type Effect

Tamer Othman, Paul B. Koller, Dongyun Yang, Sally Mokhtari, Amanda Blackmon, Vaibhav Agrawal, Hoda Pourhassan, Brian J. Ball, Idoroenyi Amanam, Shukaib Arslan, Salman Otoukesh, Karamjeet S. Sandhu, Ibrahim Aldoss, Haris Ali, Amandeep Salhotra, Ahmed Aribi, Andrew Artz, Yazeed Samara, Pamela S. Becker, Vinod Pullarkat, Forest Marc Stewart, Eileen Patricia Smith, Anthony Stein, Guido Marcucci, Stephen J. Forman, Ryotaro Nakamura, Monzr M. Al Malki
Journal: Blood
Blood (2023) 142 (Supplement 1): 2151.
https://doi.org/10.1182/blood-2023-187687
Published: 2023
Journal Articles

Covalent-103: A Phase 1, Open-Label, Dose-Escalation, and Dose-Expansion Study of Bmf-500, an Oral Covalent FLT3 Inhibitor, in Adults with Acute Leukemia (AL)

Marcello Rotta, Farhad Ravandi, Mitul Gandhi, Paul B. Koller, Gary J. Schiller, Courtney Follit, Mona Vimal, Stephan W. Morris, Sanchita Mourya, Thomas Butler, Eunice S. Wang
Journal: Blood
Blood (2023) 142 (Supplement 1): 1546.
https://doi.org/10.1182/blood-2023-182361
Published: 2023
Journal Articles

Delaying Pegaspargase Administration during Induction in Adults with Acute Lymphoblastic Leukemia

Jose Tinajero, Sharon Xu, Tina Nguyen, Dat Ngo, Anthony Stein, Paul B. Koller, Vaibhav Agrawal, Hoda Pourhassan, Vinod Pullarkat, Ibrahim Aldoss
Journal: Blood
Blood (2023) 142 (Supplement 1): 4239.
https://doi.org/10.1182/blood-2023-190566
Published: 2023
Journal Articles

Combined Cytokine Blocking Therapy (CCBT) Using Basiliximab and Infliximab for Treatment of Steroid-Refractory Graft Versus Host Disease (SR-GvHD)

Hoda Pourhassan, Tina Nguyen, Dongyun Yang, Tamer Othman, Paul B. Koller, Amanda Blackmon, Vaibhav Agrawal, Brian J. Ball, Idoroenyi Amanam, Shukaib Arslan, Salman Otoukesh, Karamjeet S. Sandhu, Ibrahim Aldoss, Haris Ali, Amandeep Salhotra, Ahmed Aribi, Andrew Artz, Pamela S. Becker, Vinod Pullarkat, Forest Marc Stewart, Eileen Patricia Smith, Anthony Stein, Guido Marcucci, Stephen J. Forman, Ryotaro Nakamura, Monzr M. Al Malki
Journal: Blood
Blood (2023) 142 (Supplement 1): 4944.
https://doi.org/10.1182/blood-2023-190808
Published: 2023
Journal Articles

Preliminary Results from a Phase 1b/2 Open-Label, Multicenter, Dose Optimization Clinical Study of the Safety, Tolerability, and Pharmacokinetic (PK) and Pharmacodynamic (PD) Profiles of Cfi-400945 As a Single Agent or in Combination with Azacitidine in Patients (Pts) with Acute Myeloid Leukemia, Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia (TWT-202)

Brian A. Jonas, Karen Yee, Alice Mims, Paul B. Koller, Joseph Brandwein, Gail J. Roboz, Glenn Michelson, Linh Nguyen, Mark R Bray, Emily Roberts-Thomson, Roger Sidhu, Gautam Borthakur
Journal: Blood
Blood (2023) 142 (Supplement 1): 4294.
https://doi.org/10.1182/blood-2023-182027
Published: 2023
Journal Articles

A Phase 1 Study of Venetoclax in Combination with a Pediatric-Inspired Regimen for the Treatment of Newly Diagnosed Adults with B-Cell Ph-like ALL

Ibrahim Aldoss, Jianying Zhang, Marjorie Robbins, Vaibhav Agrawal, Ahmed Aribi, Hoda Pourhassan, Paul B. Koller, Amanda Blackmon, Karamjeet S. Sandhu, Haris Ali, Brian J. Ball, Andrew Artz, Monzr M. Al Malki, Amandeep Salhotra, Zhaohui Gu, Asucena Leon Beltran, Christina Lai, Michelle Afkhami, Lucy Y. Ghoda, Stephen J. Forman, Guido Marcucci, Anthony Stein, Vinod Pullarkat
Journal: Blood
Blood (2023) 142 (Supplement 1): 2870.
https://doi.org/10.1182/blood-2023-187469
Published: 2023
Journal Articles

A Multicenter Analysis of Allogeneic Transplant Outcomes in Patients with Philadelphia-like (Ph-like) Acute Lymphoblastic Leukemia (ALL)

Zaid Abdel Rahman, Paul B. Koller, Tamer Othman, Rima M. Saliba, Yenny Alejandra Moreno Vanegas, Razan Mohty, Celina Ledesma, Gabriela Rondon, Nitin Jain, Elias Jabbour, Vinod Pullarkat, Hassan Alkhateeb, Hagop M. Kantarjian, Patricia Greipp, Ryotaro Nakamura, Mohamed A. Kharfan-Dabaja, Richard E. Champlin, Stephen J. Forman, Elizabeth J. Shpall, Mark R. Litzow, James M. Foran, Ibrahim Aldoss, Partow Kebriaei
Journal: Blood
Blood (2023) 142 (Supplement 1): 656.
https://doi.org/10.1182/blood-2023-178150
Published: 2023
Journal Articles

Fractionated Total Body Irradiation and Fludarabine Based Conditioning Regimen with Post-Transplant Cyclophosphamide (PTCy) for Mismatched Related and Unrelated Donors HCT for Acute Leukemia and MDS

Shukaib Arslan, Amrita Desai, Dongyun Yang, Sally Mokhtari, Amanda Blackmon, Vaibhav Agrawal, Hoda Pourhassan, Brian J. Ball, Idoroenyi Amanam, Salman Otoukesh, Paul B. Koller, Karamjeet S. Sandhu, Ibrahim Aldoss, Haris Ali, Amandeep Salhotra, Tamer Othman, Ahmed Aribi, Andrew Artz, Pamela S. Becker, Vinod Pullarkat, Forest Marc Stewart, Eileen Patricia Smith, Anthony Stein, Guido Marcucci, Stephen J. Forman, Ryotaro Nakamura, Monzr M. Al Malki
Journal: Blood
Blood (2023) 142 (Supplement 1): 3537.
https://doi.org/10.1182/blood-2023-187728
Published: 2023
Journal Articles

Toxicities Associated with Tyrosine Kinase Inhibitor Maintenance Following Allogeneic Hematopoietic Cell Transplantation in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Tamer Othman, Paul B. Koller, NI-Chun Tsai, Dat Ngo, Jason Chen, Amanda Blackmon, Hoda Pourhassan, Vaibhav Agrawal, Idoroenyi Amanam, Brian J. Ball, Salman Otoukesh, Amandeep Salhotra, Shukaib Arslan, Monzr M. Al Malki, Haris Ali, Karamjeet S. Sandhu, Ahmed Aribi, Andrew Artz, Forest Marc Stewart, Eileen Patricia Smith, Anthony Stein, Guido Marcucci, Ryotaro Nakamura, Vinod Pullarkat, Ibrahim Aldoss, Matthew Genyeh Mei
Journal: Blood
Blood (2023) 142 (Supplement 1): 2873.
https://doi.org/10.1182/blood-2023-187460
Published: 2023
Journal Articles

Single Center Retrospective Study of Midostaurin Plus Intensive Chemotherapy for Older Patients with Newly Diagnosed FLT-3 Mutated Acute Myelogenous Leukemia

Jose Tinajero, Dat Ngo, Jianying Zhang, NI-Chun Tsai, Joycelynne Michelle Palmer, Ahmed Aribi, Ibrahim Aldoss, Vaibhav Agrawal, Shukaib Arslan, Idoroenyi Amanam, Hoda Pourhassan, Karamjeet S. Sandhu, Monzr M. Al Malki, Vinod Pullarkat, Pamela S. Becker, Ryotaro Nakamura, Anthony Stein, Guido Marcucci, Andrew Artz, Paul B. Koller, Amandeep Salhotra
Journal: Blood
Blood (2023) 142 (Supplement 1): 5937.
https://doi.org/10.1182/blood-2023-173978
Published: 2023
Journal Articles

Concurrent Versus Sequential or No Triazole Anti-Fungal Therapy in Patients Undergoing 7+3 Plus Midostaurin Induction for FLT-3 Acute Myelogenous Leukemia

Dat Ngo, Jose Tinajero, Jianying Zhang, Anthony Stein, Guido Marcucci, Amandeep Salhotra, Vinod Pullarkat, Karamjeet S. Sandhu, Brian J. Ball, Paul B. Koller
Journal: Blood
Blood (2023) 142 (Supplement 1): 5932.
https://doi.org/10.1182/blood-2023-173973
Published: 2023
Journal Articles

Phase IIa Study of Adding Itacitinib to Tacrolimus/Sirolimus Gvhd Prophylaxis after Fludarabine/Melphalan-Based Conditioning Hematopoietic Cell Transplantation for Acute Leukemias, Myelodysplastic Syndrome, or Myelofibrosis

Haris Ali, Dongyun Yang, Sally Mokhtari, Timothy Synold, Idoroenyi Amanam, Andrew S. Artz, Peter T. Curtin, Karamjeet S. Sandhu, Anthony S. Stein, Shukaib Arslan, Salman Otoukesh, Firoozeh Sahebi, Joshua Mansour, Paul B. Koller, Amandeep Salhotra, Ibrahim Aldoss, Vinod A. Pullarkat, Brian J Ball, Stephen J Forman, Guido Marcucci, Monzr M. Al Malki, Ryotaro Nakamura
Journal: Blood
Blood (2022) 140 (Supplement 1): 1872–1874.
https://doi.org/10.1182/blood-2022-170323
Published: 2022